Deep Isolation Nuclear's Cash Surges Post-Merger, Losses Widen
| Field | Detail |
|---|---|
| Company | Deep Isolation Nuclear, Inc. |
| Form Type | 10-Q |
| Filed Date | Nov 14, 2025 |
| Risk Level | high |
| Pages | 15 |
| Reading Time | 19 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | mixed |
Sentiment: mixed
Topics: Nuclear Waste Disposal, Environmental Consulting, Reverse Merger, Private Placement, Cash Infusion, Net Loss, Revenue Decline
TL;DR
**Deep Isolation Nuclear just got a cash injection, but their widening losses mean it's a speculative bet on future growth, not current profitability.**
AI Summary
Deep Isolation Nuclear, Inc. reported a significant increase in cash to $28.209 million as of September 30, 2025, up from $2.149 million at December 31, 2024, primarily due to a private placement offering that raised $28.848 million. Despite this cash infusion, the company experienced a net loss of $1.307 million for the three months ended September 30, 2025, a reversal from a net income of $0.189 million in the same period of 2024. Revenue decreased to $1.683 million for the quarter, down from $2.218 million year-over-year, and for the nine months, revenue fell to $4.837 million from $5.491 million. Operating expenses surged to $2.522 million for the quarter, largely driven by a substantial increase in selling, general and administrative expenses to $2.493 million from $0.851 million in the prior year. The company completed a reverse acquisition on July 23, 2025, with Deep Isolation, Inc. becoming the accounting acquirer, and issued 11,012,387 shares in a private placement. Total stockholders' equity dramatically increased to $29.473 million from $2.917 million at December 31, 2024, reflecting the capital raise.
Why It Matters
This filing reveals Deep Isolation Nuclear's successful capital raise of nearly $29 million, providing crucial liquidity for its nuclear waste disposal and consulting services. However, the widening net losses and declining revenue, coupled with a significant jump in SG&A expenses, signal operational challenges and potential competitive pressures in the specialized environmental consulting and nuclear waste sector. Investors should scrutinize whether the increased cash will translate into improved operational efficiency and revenue growth, especially given the capital-intensive nature of nuclear technology. Employees might see increased job security due to the cash injection, while customers could benefit from enhanced service capabilities. The broader market will watch how this funding impacts the company's ability to innovate and scale in a niche but critical industry.
Risk Assessment
Risk Level: high — The company reported a net loss of $2.836 million for the nine months ended September 30, 2025, compared to a loss of $0.355 million in the prior year, indicating a significant deterioration in profitability. Revenue also declined from $5.491 million to $4.837 million year-over-year, while selling, general and administrative expenses more than doubled to $5.701 million, demonstrating a lack of cost control relative to revenue.
Analyst Insight
Investors should exercise caution and conduct thorough due diligence on Deep Isolation Nuclear's long-term strategy for achieving profitability and revenue growth. While the recent capital raise provides a lifeline, the company's increasing losses and declining revenue suggest that current operations are unsustainable without significant strategic adjustments. Monitor future filings for evidence of improved operational efficiency and market penetration.
Financial Highlights
- debt To Equity
- N/A
- revenue
- $1.683M
- operating Margin
- N/A
- total Assets
- N/A
- total Debt
- N/A
- net Income
- $(1.307)M
- eps
- N/A
- gross Margin
- N/A
- cash Position
- $28.209M
- revenue Growth
- -24.1%
Key Numbers
- $28.209M — Cash (Increased from $2.149M at Dec 31, 2024, a 1212% increase)
- $28.848M — Proceeds from Offering (Net cash provided by financing activities for nine months ended Sep 30, 2025)
- $(1.307)M — Net Loss (Q3 2025) (Compared to $0.189M net income in Q3 2024, a significant reversal)
- $1.683M — Revenue (Q3 2025) (Decreased from $2.218M in Q3 2024, a 24.1% decline)
- $2.493M — SG&A Expenses (Q3 2025) (Increased from $0.851M in Q3 2024, a 192.9% increase)
- $(2.836)M — Net Loss (YTD Sep 2025) (Compared to $(0.355)M net loss YTD Sep 2024, an 698.9% increase in loss)
- $29.473M — Total Stockholders' Equity (Increased from $2.917M at Dec 31, 2024, a 910.4% increase)
- 57,509,816 — Common Shares Outstanding (As of September 30, 2025, reflecting new issuances)
Key Players & Entities
- Deep Isolation Nuclear, Inc. (company) — registrant and combined company
- Deep Isolation, Inc. (company) — accounting acquirer in reverse merger
- Aspen-1 Acquisition Inc. (company) — legal acquirer, now Deep Isolation Nuclear, Inc.
- Deep Isolation EMEA Limited (company) — international subsidiary
- Freestone Environmental Services, Inc. (company) — acquired subsidiary
- SEC (regulator) — Securities and Exchange Commission
- $28.209 million (dollar_amount) — cash balance as of September 30, 2025
- $28.848 million (dollar_amount) — proceeds from private placement offering
- $1.307 million (dollar_amount) — net loss for three months ended September 30, 2025
- $2.493 million (dollar_amount) — selling, general and administrative expenses for three months ended September 30, 2025
FAQ
What caused the significant increase in Deep Isolation Nuclear's cash balance in Q3 2025?
Deep Isolation Nuclear's cash balance increased significantly due to proceeds from a private placement offering, which generated $28.848 million, net of offering costs, during the nine months ended September 30, 2025.
How did Deep Isolation Nuclear's revenue perform in the third quarter of 2025 compared to the previous year?
Deep Isolation Nuclear's revenue decreased to $1.683 million for the three months ended September 30, 2025, down from $2.218 million in the same period of 2024, representing a 24.1% decline.
What was Deep Isolation Nuclear's net income or loss for the nine months ended September 30, 2025?
For the nine months ended September 30, 2025, Deep Isolation Nuclear reported a net loss of $2.836 million, a substantial increase from the net loss of $0.355 million reported for the same period in 2024.
What was the impact of the reverse acquisition on Deep Isolation Nuclear's financial statements?
The reverse acquisition, completed on July 23, 2025, resulted in Deep Isolation, Inc. being deemed the accounting acquirer. Consequently, Deep Isolation's historical financial statements became the historical financial statements of the combined company, and the equity structure was retroactively restated to reflect the shares issued in connection with the merger.
How did selling, general and administrative expenses change for Deep Isolation Nuclear in Q3 2025?
Selling, general and administrative expenses for Deep Isolation Nuclear surged to $2.493 million for the three months ended September 30, 2025, a significant increase from $0.851 million in the comparable period of 2024.
What is Deep Isolation Nuclear's primary business activity?
Deep Isolation Nuclear, Inc. and its subsidiaries primarily provide nuclear waste disposal and related consulting services globally, with Deep Isolation, Inc. and its subsidiaries serving as the operating companies.
What is the current number of outstanding common shares for Deep Isolation Nuclear?
As of November 14, 2025, there were 57,509,816 shares of common stock, $0.0001 par value per share, of Deep Isolation Nuclear, Inc. outstanding.
What are the key subsidiaries of Deep Isolation Nuclear, Inc.?
Deep Isolation Nuclear, Inc.'s key subsidiaries include Deep Isolation EMEA Limited, Deep Isolation US LLC, and Freestone Environmental Services, Inc., which was acquired in November 2021.
Does Deep Isolation Nuclear have any registered securities pursuant to Section 12(b) of the Act?
No, Deep Isolation Nuclear, Inc. has no securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934.
What is the functional currency of Deep Isolation EMEA Limited?
The functional currency of Deep Isolation EMEA Limited, Deep Isolation Nuclear's foreign subsidiary, is generally the local currency of the country in which it operates, specifically British Pound Sterling.
Risk Factors
- Uncertainty in Nuclear Waste Disposal Regulations [high — regulatory]: The company's core business relies on the development of deep geological repositories for nuclear waste. Evolving and uncertain regulatory frameworks at federal and state levels could significantly impact project timelines, costs, and ultimate feasibility. Delays in obtaining permits or changes in licensing requirements pose a substantial risk.
- Dependence on Future Financing and Capital Intensive Operations [high — financial]: Deep Isolation Nuclear, Inc. has a history of net losses and significant operating expenses. The company's ability to fund its research, development, and eventual operational phases is heavily reliant on continued access to capital through equity or debt financings. A failure to secure necessary funding could impede progress and operational viability.
- Technical and Execution Risks of Deep Geological Repositories [high — operational]: The successful design, construction, and operation of deep geological repositories present complex technical challenges. Unforeseen geological conditions, engineering hurdles, or long-term safety concerns could lead to significant cost overruns, project delays, or even project failure. The company's success is contingent on overcoming these substantial technical risks.
- Limited Market and Public Acceptance of Nuclear Waste Solutions [medium — market]: The market for deep geological disposal of nuclear waste is nascent and faces significant public perception challenges. Gaining social license and community acceptance for repository sites is critical and can be a lengthy and unpredictable process. Negative public sentiment or local opposition could halt development.
- Significant Increase in SG&A Expenses [medium — financial]: Selling, General, and Administrative (SG&A) expenses increased by 192.9% to $2.493 million in Q3 2025 from $0.851 million in Q3 2024. This surge, while potentially linked to the reverse acquisition and private placement activities, indicates rising overhead costs that need to be managed alongside revenue generation.
- Declining Revenue and Profitability Reversal [medium — financial]: Revenue for Q3 2025 decreased by 24.1% to $1.683 million from $2.218 million in Q3 2024. Furthermore, the company swung from a net income of $0.189 million in Q3 2024 to a net loss of $1.307 million in Q3 2025. This trend highlights current challenges in revenue generation and cost control.
Industry Context
The nuclear waste management industry is characterized by long project lead times, high capital requirements, and significant regulatory oversight. Companies in this sector focus on developing safe and secure long-term disposal solutions, often facing public scrutiny and complex geological challenges. The market is driven by the need to manage existing nuclear waste from power generation and research.
Regulatory Implications
Deep Isolation Nuclear, Inc. operates in a highly regulated environment. Obtaining and maintaining licenses for deep geological repositories is a complex, lengthy, and uncertain process. Changes in federal or state regulations regarding nuclear waste disposal could significantly impact the company's ability to operate and its long-term viability.
What Investors Should Do
- Monitor SG&A expense trends closely: The significant increase in SG&A needs to be justified by future revenue growth and operational efficiency to avoid continued net losses.
- Evaluate the sustainability of cash position: While cash is high due to the offering, understand the burn rate and future capital needs for project development.
- Assess progress on regulatory approvals: Key milestones in obtaining permits and licenses are critical indicators of future operational success and market entry.
- Analyze revenue drivers: Understand the reasons behind the revenue decline and the strategy to reverse this trend in future periods.
Key Dates
- 2025-07-23: Reverse Acquisition Completed — Deep Isolation, Inc. became the accounting acquirer, fundamentally changing the company's structure and financial reporting basis. This event is crucial for understanding the current financial statements.
- 2025-09-30: End of Third Quarter — Reporting period for the latest 10-Q, showing a significant cash increase from a private placement but also a net loss and declining revenue.
Glossary
- Reverse Acquisition
- A transaction where a private company acquires a public company, and the private company's shareholders end up controlling the combined entity. The private company is treated as the acquirer for accounting purposes. (Deep Isolation, Inc. underwent a reverse acquisition on July 23, 2025, meaning it is the accounting acquirer, impacting how its financial results are presented.)
- Private Placement Offering
- A sale of securities (like stock) to a select group of investors, rather than through a public offering. It's often used by companies seeking capital quickly. (The company raised $28.848 million through a private placement, significantly boosting its cash reserves.)
- Stockholders' Equity
- The residual interest in the assets of an entity after deducting all its liabilities. It represents the net worth of the company from an accounting perspective. (Total stockholders' equity increased dramatically to $29.473 million from $2.917 million, primarily due to the capital raised in the private placement.)
Year-Over-Year Comparison
Compared to the prior year's comparable period, Deep Isolation Nuclear, Inc. has seen a significant increase in cash reserves, largely due to a recent private placement. However, this financial injection has not yet translated into improved operational performance. Revenue has declined, and the company has swung from a net income to a substantial net loss. Operating expenses, particularly SG&A, have surged, indicating increased costs associated with the company's growth and recent transactions.
Filing Stats: 4,636 words · 19 min read · ~15 pages · Grade level 15.8 · Accepted 2025-11-14 16:17:10
Key Financial Figures
- $0.0001 — ding 57,509,816 shares of common stock, $0.0001 par value per share, of the registrant.
Filing Documents
- ea0265435-10q_deep.htm (10-Q) — 2103KB
- ea026543501ex31-1_deep.htm (EX-31.1) — 10KB
- ea026543501ex32-1_deep.htm (EX-32.1) — 4KB
- 0001213900-25-110860.txt ( ) — 9390KB
- ck0001918080-20250930.xsd (EX-101.SCH) — 56KB
- ck0001918080-20250930_cal.xml (EX-101.CAL) — 55KB
- ck0001918080-20250930_def.xml (EX-101.DEF) — 306KB
- ck0001918080-20250930_lab.xml (EX-101.LAB) — 540KB
- ck0001918080-20250930_pre.xml (EX-101.PRE) — 330KB
- ea0265435-10q_deep_htm.xml (XML) — 1637KB
FINANCIAL INFORMATION
PART I. FINANCIAL INFORMATION 1
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) 1 NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 6 ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 28
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 36
CONTROLS AND PROCEDURES
ITEM 4. CONTROLS AND PROCEDURES 36
OTHER INFORMATION
PART II. OTHER INFORMATION 37
LEGAL PROCEEDINGS
ITEM 1. LEGAL PROCEEDINGS 37
RISK FACTORS
ITEM 1A. RISK FACTORS 37
UNREGISTERED SALES OF EQUITY SECURITIES AND
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND
OTHER INFORMATION
ITEM 5. OTHER INFORMATION 59
EXHIBITS
ITEM 6. EXHIBITS 60 i PART I. FINANCIAL INFORMATION ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Deep Isolation Nuclear, Inc. and Subsidiaries Condensed Consolidated Balance Sheets (in thousands, except share and per share data) September 30, 2025 (Unaudited) December 31, 2024 Assets Current assets: Cash $ 28,209 $ 2,149 Accounts receivable, net of allowance for credit losses of $ 112 and $ 128 , respectively 1,515 999 Contract assets 141 111 Other current assets 1,048 80 Total current assets 30,913 3,339 Property, plant and equipment, net 67 55 Intangible assets, net 93 153 Finance lease right-of-use assets 12 14 Operating lease right-of-use assets 299 387 Goodwill 182 182 Total assets $ 31,566 $ 4,130 Liabilities and Stockholders' Equity Current liabilities: Accounts payable $ 779 $ 174 Accrued payroll 345 519 Contract liabilities 414 - Finance lease liabilities, current 3 3 Operating lease liabilities, current 122 116 Other current liabilities 236 112 Total current liabilities 1,899 924 Finance lease liabilities, net of current portion 9 12 Operating lease liabilities, net of current portion 185 277 Total liabilities 2,093 1,213 Commitments and Contingencies (Note 16) Stockholders' Equity Series A Convertible Preferred Stock, par value $ 0.0001 per share, none and 17,604,052 shares authorized, no shares issued and outstanding as of September 30, 2025 and December 31, 2024 - - Series A Prime Convertible Preferred Stock, par value $ 0.0001 per share, none and 5,148,983 shares authorized, no shares issued and outstanding as of September 30, 2025 and December 31, 2024 - - Common stock, par value $ 0.0001 per share, 300,000,000 and 55,550,158 shares authorized, 57,509,816 and 19,996,529 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively 5 - Additional paid-in capital 59,229 29,962 Accumula